Zhao et al. found that inhibition of galectin-3 resulted in smaller tumour size and fewer metastases in a co-implanted murine model of pancreatic cancer cells and pancreatic stellate cells (PSCs). This evidence concerns the gene LGALS3 and familial pancreatic carcinoma.